Research Article - Journal of RNA and Genomics (2022) Volume 0, Issue 0

Microneedles for Covid-19 Vaccination

Transdermal Drug Delivery System (TDDS) has not been used in majority of the countries, and the ones that use them have this system not as primary, but secondary choice of use. It is mainly because of the limitations they have previously faced in some cases. But, as a result of progressive evolution of TDDS from 1st Generation to 3rd Generation, there have been major changes and improvements which resolved the older limitations. Now days, TDDS and more specially the type Micro needle (MNs), could also deliver vaccines, and there are many researches and clinical trials occurred and are being proposed time to time, which are showing successful results. Over the past researches and clinical trials, the results depict that using MNs for vaccine delivery have many advantages, especially in view of any calamity or pandemic, like COVID-19. This review article has a main purpose of focusing that MNs would be the most prominent choice for COVID-19 vaccine delivery over injection or syringes, which will be a life changing happening for health care against fighting with pandemics using cost effective, easy and efficacious drug delivery system.

Author(s): Chattopadhyay B , Pawaiya A, Jain UK

Abstract PDF